News and Events

Public Policy

 California recently enacted a law, Chapter 645, that includes a requirement for accreditation agencies to report accreditation denials of outpatient facilities to the state medical board within 3 days. Any denial, revocation, or suspension of accreditation will apply to all other accrediting agencies so that facilities are not able to search for a potentially favorable agency to counter a negative review.

Please click here for an article in the Los Angeles Times that appeared before the law’s passage that describes the circumstances that lead to the increased scrutiny of these facilities.

 

Guest articles

CACC business case template for assessment to justify additional FTE’s needed to comply with the SB 1058 and AFL 11-32-Requirements for Reporting Surgical Site Infections

 In our best expert opinion it would take roughly 60 minutes per chart based on the 30 day and 1 year review for implants. This may vary per GACH based on their ability to automatically vs manually upload data and how resourced their current IC program is.

 

Read More...

Recommendations for Tdap Vaccine Updated

To help prevent pertussis infection in newborns, who are too young to be immunized, the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) booster vaccine should be administered to pregnant women who have not previously received Tdap, according to a guideline update from the CDC's Advisory Committee on Immunization Practices (ACIP).

The new recommendation, published in MMWR, replaces previous guidance that Tdap be given to women immediately postpartum. New safety data now support its use during pregnancy, preferably after 20 weeks' gestation. In addition, maternal pertussis antibodies pass to the fetus and "likely confer protection" to the infant without diminishing the infant's own antibody response to later vaccination, ACIP says.

Adolescents and adults who have not received Tdap and who anticipate close contact with an infant under 12 months of age should also receive the booster, ideally 2 weeks before contact with the infant.  http://www.cdc.gov/mmwr/pdf/rr/rr6002.pdf